The healthcare sector faced a whirlwind of challenges and opportunities in Q1, from major acquisitions to regulatory uncertainties. What will Q2 bring for biotech and pharma?
Revolutionizing Photodynamic Therapy (PDT) for cancer and infectious diseases
Biomarker technologies and digital solutions to address the world’s largest health disorders.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â
